CYP8B1 and Hypercholesterolemia: In summary, these findings reveal that Cyp8b1-/- mice with a BA pool abundant in MCAs are protected against the development of several stigmata of the metabolic syndrome such as body and liver weight gain, steatosis, hypercholesterolemia and insulin resistance.